New offering · Form C
A company's offering statement — it's kicking off a Regulation Crowdfunding raise.
Circumvent Pharmaceuticals, Inc.
www.circumventpharmaceuticals.com · DE · Filed Jul 12, 2021
Circumvent Pharmaceuticals, Inc. filed a Form C — new offering — with the SEC on Jul 12, 2021. The Regulation Crowdfunding offering seeks $25,000, up to a maximum of $250,000 on Bioverge. Investors receive: Other at $25,000.00. The offering closes 12-31-2021.
| Target raise | $25,000 |
|---|---|
| Maximum raise | $250,000 |
| Security | Other @ $25,000.00 |
| Closes | 12-31-2021 |
| Portal | Bioverge |
| SEC file number | 020-28374 · every filing in this offering |
Filing documents
ea144006.pdf
The summary above is auto-extracted from the filing’s structured data on the SEC’s EDGAR system and shown for easy reading. Always confirm details against the official filing before acting. Inclusion here is not a recommendation or endorsement.
SuperCrowd